Holen Sie sich die Stockscreener-App
1.69
9.14%
-0.17
Handel nachbörslich:
1.76
0.07
+4.14%
Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
14.81%
0.093
|
0.081 | 1.806 | 0.194 | - |
Operating Expenses
|
14.76%
1.765
|
1.538 | 1.304 | 1.322 | 1.384 |
| Benefits Costs and Expenses |
100.00%
-
|
1.51 | 1.276 | 0.917 | - |
| Costs And Expenses |
16.89%
1.765
|
1.51 | 1.276 | 0.917 | - |
| Operating Income/Loss |
14.76%
-1.672
|
-1.457 | 0.502 | -1.128 | -1.384 |
| Nonoperating Income/Loss |
4,714%
1.348
|
0.028 | 0.028 | 0.405 | 0.062 |
| Income/Loss From Continuing Operations Before Tax |
106.51%
0.093
|
-1.429 | 0.53 | -0.723 | -1.322 |
| Income/Loss From Continuing Operations After Tax |
77.33%
-0.324
|
-1.429 | 0.53 | -0.723 | -1.322 |
|
Net Income/Loss
|
77.33%
-0.324
|
-1.429 | 0.53 | -0.723 | -1.322 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
20.15%
3.071
|
2.556 | 0.008 | 2.526 | 2.51 |
| Diluted Average Shares |
20.15%
3.071
|
2.556 | 0.008 | 2.526 | 2.51 |
| Basic Earnings Per Share |
80.36%
-0.11
|
-0.56 | 0.22 | -0.29 | -0.53 |
| Diluted Earnings Per Share |
80.36%
-0.11
|
-0.56 | 0.22 | -0.29 | -0.53 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):